Status:
COMPLETED
Tetragraph® Monitor: Tolerance of Preoperative Placement
Lead Sponsor:
Joseph D. Tobias
Conditions:
Surgery
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
This is a prospective, non-blinded, single arm study. The primary objective of this study is to evaluate the tolerance to preoperative placement of the adhesive sensor for the Tetragraph® Neuromuscula...
Eligibility Criteria
Inclusion
- Patients requiring anesthetic care and use of neuromuscular blockade
- Age ≤ 12 years
- ASA 1-4
Exclusion
- History of a peripheral neurologic or neuropathic disorder
- Upper extremity cannot be used for TOF monitoring
- Undergoing a surgical procedure in which neuromuscular blockade is not required
- Patient is edematous
- Patients with significant behavioral or neurocognitive issues which affect behavior and impact the ability to place the sensor
Key Trial Info
Start Date :
May 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05964166
Start Date
May 31 2023
End Date
August 1 2023
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205